Search Results
67 items found for "Yu-Ting Dai"
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
ENDO 2022 "06/13/22 - Substantial Reductions in Key Hormones and Hormone Precursors Observed After 14 Days
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Get your 5-day free trial TODAY!
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Methods: Rats were divided into sham, sham + Exendin-4 (10 μg/day, i.p), MI, and MI + Exendin-4. Results: On day 7 post-infraction, MI rats showed LV dysfunction with higher serum levels of cardiac
- 📰 GPCR Weekly News, July 10 to 16, 2023
The symposium will feature a trainee day with a career panel. Remember to subscribe to Dr.
- 📰 GPCR Weekly News, October 23 to 29, 2023
Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100 Sosei Heptares to Host R&D Day
- All Aboard the GPCR Express: Your Weekly Update is here! Oct 14-20, 2024
Get your 5-day free trial TODAY!
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Get your 5-day free trial TODAY!
- 📰 GPCR Weekly News, May 20 to 26, 2024
GPCR University Today marks the final day of the Dr.
- 📰 GPCR Weekly News, May 1 to 7, 2023
Good day readers! We've got some GPCR updates to share with you. Take a look 👀!
- 📰 GPCR Weekly News, August 14 to 20, 2023
Don't miss the 3rd ECI GPCR 2-day symposium organized by and for early career investigators (ECIs) exploring
- 📰 GPCR Weekly News, September 25 to October 1, 2023
CXCR4 attenuates CXCL12-induced signaling and cell migration Respiratory infections predominate after day
- 📰 GPCR Weekly News, September 4 to 10, 2023
Good day readers! Welcome to our latest GPCR updates. This week's highlights: Dr. the 5-HT2C receptor as a therapeutic target for substance use disorders Industry News Crinetics’ Once-Daily
- 📰 GPCR Weekly News, April 3 to 9, 2023
(April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) NEW ASPET 2023 - American Society for Pharmacology
- 📰 GPCR Weekly News, April 15 to 21, 2024
Protein Coupled Receptors (GPCRs): a historical perspective Monserrat Avila-Zozaya article on From DNA day
- 📰 GPCR Weekly News, March 20 to 26, 2023
(April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Get your 5-day free trial TODAY!
- 📰 GPCR Weekly News, June 26 to July 2, 2023
The exciting news is that this Symposium will be a trainee day with a career panel. GPCR Activation and Signaling Trans-palmitoleic acid, a dairy fat biomarker, stimulates insulin secretion
- 📰 GPCR Weekly News, April 10 to 16, 2023
(April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) ASPET 2023 - American Society for Pharmacology
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Get your 5-day free trial TODAY!
- 📰 GPCR Weekly News, March 13 to 19, 2023
(April 20 - 21, 2023) NEW Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Good day, GPCR folks! Take advantage of our GPCR highlights of the week. Dr.
- 📰 GPCR Weekly News, May 29 to June 4, 2023
We look forward to seeing you in a few days at the Molecular Pharmacology GRC and the associated Molecular
- New role of β-arrestins in MOR signaling
With around 187 people dying every day from an opioid overdose in the U.S., combatting the opioid overdose
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Industry News Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Part 1 Domain Therapeutics to Participate in Upcoming Investor and Industry Conferences International Day
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
This leads to strikingly long in vitro receptor occupancy durations (at least seven days), meaning that Twice-daily treatment with mOB-004 dose-dependently suppressed monocyte infiltration into the peritoneum
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
We have explored hydrophobic groups of different sizes on both sides of the five-membered ring scaffold